NeoGenomics to Participate in Upcoming Investor Conferences
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
NeoGenomics Reports Third Quarter 2025 Results
Quarterly report [Sections 13 or 15(d)]
Current report
Definitive proxy statements
View and filter by group or type
